Senate Health Committee advances social media warning-labels, menopause coverage, hospital financial-assistance screening and other health bills

The Senate Committee on Health on Monday advanced a slate of bills aimed at public health and health-care access, including a proposal to require warning labels on social media (AB 56), an insurance coverage bill for menopause care (AB 432), a measure to require hospitals to screen patients for financial assistance before billing (AB 1312), and a bill to require trained chaperones be made available for ultrasound exams of sensitive areas (AB 849).

Supporters framed the measures as steps to protect vulnerable Californians and expand access to care. Victoria Hinks, a mother who lost her 16-year-old daughter to suicide, urged passage of AB 56, the social media warning-label bill, saying in testimony, “Please vote like a mom. Please support AB 56” (testimony excerpted from committee hearing). Anthony Liu, deputy attorney general, told the committee the Attorney General’s Office and a bipartisan coalition of 42 state attorneys general back a Surgeon General advisory and support a warning-label approach as “an equitable, effective, and transparent way to deliver public health information.”

Industry groups and technology trade associations opposed AB 56, saying the measure could be ineffective, technically burdensome, and vulnerable to First Amendment challenge. Dylan Hoffman of TechNet said the proposed labels “flatten an incredibly complex, nuanced and evolving issue to the point of overgeneralization,” and cautioned the bill is “highly likely to be challenged in court.” The committee’s author and AG staff argued the warning language was tailored to meet applicable legal tests for factual, noncontroversial health warnings.

AB 432, the Menopause Equity Act, drew personal testimony and a broad coalition of medical and patient groups. The bill’s author described personal experience with perimenopause and said the measure would require insurers to cover clinically appropriate treatments, including some nonhormonal options. Halle Berry provided written testimony read into the record; health-plan groups objected to provisions that would limit utilization management for some menopausal therapies, saying the language as printed could allow overly broad coverage of costly drugs without oversight. Committee amendments taken during the hearing addressed continuing concerns about utilization management and in‑network provider requirements.

AB 1312 would require hospitals to screen patients for financial assistance and to apply eligible patients for charity or discounted care before they are billed. Patient advocates and families described being unaware of available hospital financial assistance and urged standardization; Monica Padilla told the committee her family applied for assistance late in a long pediatric cancer treatment and said “we could have focused on treatment instead of worrying about bills.” Hospitals and hospital associations said they already offer financial assistance but asked for operational clarifications and time to implement standardized presumptive‑eligibility processes; the author accepted amendments to delay implementation and to refine verification rules.

Other items advanced included AB 554 (codifying coverage and reimbursement rules for long‑acting injectable HIV pre‑exposure prophylaxis), which supporters said will reduce administrative delays that can result in gaps in prevention; AB 836 (a statewide study on midwifery education to expand workforce capacity); AB 592 (extending pandemic-era outdoor dining and permitting open kitchens with pest- and risk-mitigation plans); and AB 849 (requiring notice and training so medical chaperones can identify and intervene if they observe concerning conduct during ultrasounds of sensitive areas). The ultrasound bill was driven by survivor testimony; one witness told the committee she was assaulted during an ultrasound and said the chaperone in the room “was facing away from me…entirely engaged in her phone.” Hospitals raised staffing and implementation concerns and the author pledged to continue working with stakeholders.

AB 1084, a measure intended to expedite court-ordered name and gender changes for transgender and nonbinary people, produced a sharp partisan and public debate. Supporters said the bill would shorten delays for people seeking identity documentation and would remove an inflexible deadline for filing related vital-records changes. Opponents warned the bill as drafted could limit public notice and raise public-safety and parental‑rights concerns; they urged the Legislature to preserve existing judicial safeguards and notice processes.

Committee votes and motions were conducted during the hearing; several bills were reported out of committee and sent to the Appropriations Committee for further consideration.

Votes at a glance - AB 56 (social media warning labels) — advanced from committee; committee vote reported as 10–0 in favor during the roll call portion of the hearing. - AB 432 (Menopause Equity Act) — advanced from committee as amended; motion to pass was recorded and the bill was referred to Appropriations. - AB 554 (PrEP coverage and reimbursement clarifications) — advanced from committee as amended. - AB 1312 (hospital financial-assistance presumptive screening) — advanced as amended; implementation provisions delayed to allow operational preparation. - AB 849 (chaperones for sensitive ultrasounds) — advanced as amended; author committed to further stakeholder work on training and staffing. - AB 1084 (expedited name/gender change orders) — advanced from committee; generated robust opposition and discussion; committee action moved the bill forward for further consideration.

What happens next Most bills the committee advanced were referred to the Senate Appropriations Committee for fiscal review and potential floor consideration. Committee members and bill authors said they will continue to refine language in response to stakeholders’ operational concerns and legal questions before further legislative steps.

(End)